China Approves 5 New COVID-19 Vaccines for ‘Emergency Use’ Amid Worsening Pneumonia Outbreak

Published on December 6, 2023

Five major Chinese pharmaceutical companies recently announced that Beijing approved their newly developed COVID-19 vaccines for “emergency use” amid the fast-worsening pneumonia outbreak in China. Meanwhile, authorities have reinstated COVID-19 control measures, including PCR testing and health codes, in various locations nationwide. Nevertheless, the ruling Chinese Communist Party’s (CCP) health authorities continue to provide conflicting information regarding the surge in pneumonia infections, particularly among children, since mid-October, refraining from calling it a new COVID-19 outbreak. Experts believe the CCP is once again attempting to conceal information, which is reminiscent of its actions at the onset of the pandemic in late 2019, to safeguard the regime’s political security....